Larvol Delta - A-PanRAS-Inhibitor-in-Combination-With-AntiTumor-Therapy-in-Participants-With-Advanced-Pancreatic-Cancer

AiRuiLi (adebrelimab) - Jiangsu Hengrui Pharma

TheraCIM (nimotuzumab) - Daiichi Sankyo, Biocon, Biotech Pharma

risvutatug rezetecan (GSK5764227) - GSK

HRS-2329 - Jiangsu Hengrui Pharma

http://clinicaltrials.gov/ct2/show/NCT07736612

Jul 31, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next